• Home
  • News
  • 2020 IPOS Award Nominations – Submit by January 31!

2020 IPOS Award Nominations – Submit by January 31!

5 Nov 2019 9:58 AM | John Chagnon (Administrator)

Awards will be presented at the 22nd Annual World Congress in Kyoto, Japan, June 16-19, 2020. SUBMIT YOUR NOMINATIONS BY JANUARY 31, 2020!


Please note:

  1. ANYONE and EVERYONE can submit nominations;
  2. There is no cost to nominate and/or submit a nomination;
  3. Nominations are kept in strict confidence - only the Awards Committee and Reviewers (void of any conflict of interest) are aware of nominees;
  4. We will confirm within three business days once your nomination is received.

FIVE AWARDS TO SELECT FROM:

  1. The Jimmie Holland Memorial Award honors an IPOS or psycho-oncology community member, recognized for making a unique contribution that is considered to be a highly creative or pioneering innovation or activity that advances the field of Psycho-oncology. The award is unique in its recognition of Jimmie Holland as a pioneer and chief innovator of our time, as well as for her enormous contribution as a mentor. This award is considered for nominees within early to senior levels of careers with documentation and support to provide clear evidence of what is “visionary or outside the box” about the activity and how it represents an outstanding idea or activity or line of work, within the chosen area of the field of psycho-oncology. It is important that the nominator provide evidence in his/her letter of recommendation that the nominee meets the criteria. In addition, the nominator needs to provide two further letters of recommendation from other individuals to whom the nominee is known which, provides evidence that the nominee meets these criteria. 
  2. The Arthur M. Sutherland Award honors an IPOS or psycho-oncology community member with a lifetime achievement in the field of psycho-oncology. This is a late career award and recognizes sustained and distinguished output in psycho-oncology over their whole career. This is the Society’s most important award and reflects the international standing of the recipient. The recipient will have achieved international recognition for his/her work and be considered to have contributed important innovations to the field of psycho-oncology. Quantity of output is less important than evidence of international standing and innovation across an individual’s whole career. It is important that the nominator provides evidence in their letter of recommendation that the nominee meets these criteria. In addition, the nominator needs to provide two further letters of recommendation from other individuals to whom the nominee is known, which provide evidence that the nominee meets these criteria. This award will be presented at the next IPOS World Congress of Psycho-Oncology. The award recipient will be invited to present an overview on a topic related to their research as part of a plenary session of the IPOS World Congress. 
  3. The Bernard Fox Memorial Award honors an IPOS or psycho-oncology community member who has made an outstanding contribution in education or research to the field of psycho-oncology. The primary focus is on the academic and educational output of the nominee. This is a mid to late career award, and the nominee may work as an educator, as a researcher and/or provide clear evidence of being a leader in his/her chosen area of psycho-oncology. It is important that the nominator provides evidence in his/her letter of recommendation that the nominee meets these criteria. In addition, the nominator needs to provide two further letters of recommendation from other individuals to whom the nominee is known, which provide evidence that the nominee meets these criteria.
  4. The Noemi Fisman Award for Lifetime Clinical Excellence honors an IPOS or psycho-oncology community member in recognition of outstanding clinical contributions to the field of psycho-oncology. He/she must have served for a major proportion of his/her career as a clinician and be able to demonstrate novel, beneficial and substantial initiatives impacting directly on the care of patients and his/her families either through their own practice or practice developments. Candidates must be licensed and have been actively practicing in the field of clinical psycho-oncology for a minimum of 20 years. The award focuses on the distinctive contribution made in developing services to patients and families. Innovation and sustained successful clinical service of outstanding character should be what distinguishes the recipient of this award. It is important that the nominator provide evidence in his/her letter of recommendation that the nominee meets these criteria. In addition, the nominator needs to provide two further letters of recommendation from other individuals to whom the nominee is known, which provide evidence that the nominee meets these criteria.
  5. The Hiroomi Kawano New Investigator Award honors a new investigator for outstanding research contributions in the field of psycho-oncology and is an early career award. Candidates must be within seven years of active work in psycho-oncology after completing his/her postgraduate, fellowship or equivalent specialist training (defined as a PhD or MD or equivalent). This award is sponsored by the Hiroomi Kawano Foundation in Japan. The award is linked to professional attainment rather than to age. Recipients are distinguished by the level and quality of research output at this early career stage. It is important that the nominator provides evidence in his/her letter of recommendation that the nominee meets these criteria. In addition, the nominator needs to provide two further letters of recommendation from other individuals to whom the nominee is known, which provide evidence that the nominee meets these criteria.

Awards Criteria:

  • All award nominations must include a completed and signed nomination form, a letter of nomination from the nominator, two letters of support for the nomination from other individuals to whom the nominee is known, the curriculum vitae or resume of the nominee, and any additional paperwork required by the specific award for which the individual is being nominated.
  • Award recipients must be available to attend the IPOS World Congress at which the award is to be presented.
  • For all awards, consideration may be given for travel reimbursement and/or registration fee waiver, if required.
  • Each award shall have a peer review panel consisting of at least: (a) one previous recipient of the award, (b) one member of the Federation, and (c) one member of the Awards Committee.
  • An award recipient may receive only one Society award in any calendar year.
  • No recipient of an IPOS Award shall be eligible for nomination to a second or subsequent award within a period of 10 years from the date of their previous award.
  • The Society Treasurer shall review, ratify where required and advise on all financial recommendations and requests made by the Awards Committee.
  • Specific criteria for each award are identified below.

Find out more by going to https://ipos-society.org/awards


International Psycho-Oncology Society
1 - 189 Queen Street East
Toronto, ON M5A 1S2

244 Fifth Avenue, Suite L296
New York, NY 10001

T: +1 416-968-0260
F: +1 416-968-6818
[email protected]



Follow IPOS

© 2019 International Psycho-Oncology Society 

 Website powered by Funnel Communications Inc.